Last ¥1,005 JPY
Change Today +9.00 / 0.90%
Volume 1.1M
8086 On Other Exchanges
Symbol
Exchange
Tokyo
OTC US
As of 1:00 AM 11/26/14 All times are local (Market data is delayed by at least 15 minutes).

nipro corp (8086) Snapshot

Open
¥997.00
Previous Close
¥996.00
Day High
¥1,010
Day Low
¥995.00
52 Week High
11/21/14 - ¥1,010
52 Week Low
05/21/14 - ¥828.00
Market Cap
172.3B
Average Volume 10 Days
1.6M
EPS TTM
¥37.87
Shares Outstanding
171.5M
EX-Date
03/27/15
P/E TM
26.5x
Dividend
¥32.50
Dividend Yield
3.23%
Current Stock Chart for NIPRO CORP (8086)

Related News

No related news articles were found.

nipro corp (8086) Related Businessweek News

View More BusinessWeek News

nipro corp (8086) Details

Nipro Corporation, together with its subsidiaries, engages in the medical equipment, pharmaceuticals, and glass businesses in Japan, the United States, Europe, and rest of Asia. The company’s Medical-Related Business segment offers injection and infusion products, artificial organ products, functional products, dialysis products, and diabetic products, as well as renal, intervention and anesthesiology, cardiopulmonary, and pharmaceutical kit products. Its Pharmaceutical-Related Business segment provides injectable drugs, including injection kits, etc.; oral drugs, such as orally-disintegrating tablets, etc.; generic anti-cancer drugs and biosimilars; and drugs for external use. The company’s Glass-Related Business segment offers tube glass for pharmaceuticals, vials, and ampoules; and glass material products for thermos bottles and lighting. Nipro Corporation is also involved in the rental of real estate properties. The company was founded in 1954 and is headquartered in Osaka, Japan.

21,826 Employees
Last Reported Date: 06/26/14
Founded in 1954

nipro corp (8086) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

nipro corp (8086) Key Developments

Nipro Corporation to Report Q2, 2015 Results on Nov 12, 2014

Nipro Corporation announced that they will report Q2, 2015 results on Nov 12, 2014

Nipro Corporation, Q2 2015 Earnings Call, Nov 19, 2014

Nipro Corporation, Q2 2015 Earnings Call, Nov 19, 2014

Nipro Corporation Reports Consolidated Earnings Results for the First Quarter Ended June 30, 2014; Provides Earnings Guidance for the Six Months Ending September 30, 2014 and for the Year Ending March 31, 2015

Nipro Corporation reported consolidated earnings results for the first quarter ended June 30, 2014. For the period, the company reported net sales of JPY 75,424 million against JPY 70,093 million a year ago. Operating income was JPY 2,801 million against JPY 2,534 million a year ago. Income before income taxes and minority interests was JPY 3,458 million against JPY 5,106 million a year ago. Net income was JPY 1,252 million or JPY 7.40 per diluted share against JPY 2,441 million or JPY 12.92 per diluted share a year ago. For the six months ending September 30, 2014, the company expected net sales of JPY 155,000 million, operating income of JPY 7,800 million and net income of JPY 2,150 million or JPY 14.26 per share. For the year ending March 31, 2015, the company expected net sales of JPY 330,000 million, operating income of JPY 20,000 million and net income of JPY 6,700 million or JPY 44.45 per share.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
8086:JP ¥1,005.00 JPY +9.00

8086 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Dr Reddy's Laboratories Ltd 3,556 INR -17.20
JMS Co Ltd ¥291.00 JPY +2.00
Nikkiso Co Ltd ¥1,167 JPY -1.00
NxStage Medical Inc $17.58 USD -0.03
Perrigo Co PLC $156.47 USD -0.42
View Industry Companies
 

Industry Analysis

8086

Industry Average

Valuation 8086 Industry Range
Price/Earnings 27.3x
Price/Sales 0.4x
Price/Book 1.1x
Price/Cash Flow 27.7x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NIPRO CORP, please visit www.nipro.co.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.